<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00965991</url>
  </required_header>
  <id_info>
    <org_study_id>HRRC#03-277</org_study_id>
    <nct_id>NCT00965991</nct_id>
  </id_info>
  <brief_title>Metformin Compared to Glyburide in Gestational Diabetes</brief_title>
  <official_title>A Randomized Prospective Trial of Metformin Compared to Glyburide in Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our hypothesis is that metformin and glyburide will have equal efficacy in controlling blood
      glucose in gestational diabetics with no increase in adverse maternal, fetal or neonatal
      outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pregnant women are screened with a one hour 50g glucose challenge. Women with values of 130
      mg/dl or greater are then given a 100g glucose tolerance test. Two abnormal values are
      diagnostic of gestational diabetes. all women are initially counseled on diet and exercise.
      Women who fail to maintain a fasting of &lt;105mg/dl and 2 hr postprandial &lt; 120 mg/dl are
      offered participation in the study. Women were randomized to either metformin or glyburide
      via a computer generated randomization. Women who fail to meet glycemic goals after receiving
      the maximum dose of study medication were considered treatment failures and insulin therapy
      was initiated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glucose control</measure>
    <time_frame>fasting and 2 hour postprandial blood glucose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>birthweight</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delivery method</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>failure rate of the drug to control blood glucose</measure>
    <time_frame>at weekly visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fetal macrosomia</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal hypoglycemia</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal hypoglycemia</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>birth trauma</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NICU admission</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGARs</measure>
    <time_frame>postpartum</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">149</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Glyburide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>metformin</intervention_name>
    <description>patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose</description>
    <arm_group_label>Metformin</arm_group_label>
    <other_name>Glucophage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glyburide</intervention_name>
    <description>Initial dose of 2.5mg PO BID increased as necessary to a maximum dose of 20 mg (10mg BID) QD to control blood glucose</description>
    <arm_group_label>Glyburide</arm_group_label>
    <other_name>sulfonylurea</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational diabetes not controlled with diet and exercise

        Exclusion Criteria:

          -  history of alcohol misuse

          -  history of drug misuse

          -  Chronic hypertension requiring medication

          -  Renal failure

          -  Hepatic disease or dysfunction

          -  Known fetal anomaly

          -  Inability to give consent

          -  known allergy to metformin or glyburide
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa E Moore, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico Diabetes in Pregnancy Clinic</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010 Jan;115(1):55-9. doi: 10.1097/AOG.0b013e3181c52132.</citation>
    <PMID>20027034</PMID>
  </results_reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2009</study_first_submitted>
  <study_first_submitted_qc>August 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2009</study_first_posted>
  <last_update_submitted>June 23, 2010</last_update_submitted>
  <last_update_submitted_qc>June 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Lisa E. Moore,MD</name_title>
    <organization>University of New Mexico</organization>
  </responsible_party>
  <keyword>Gestational diabetes</keyword>
  <keyword>Metformin</keyword>
  <keyword>Glyburide</keyword>
  <keyword>oral agents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Glyburide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

